| Typicality: | 0.301 |
| Saliency: | 0.121 |
| in these immune-mediated diseases | 3 | location |
| mechanism → underlie → beneficial effects | 3 |
| mechanism → underlie → its beneficial effects | 3 |
| negative | neutral | positive |
| 0.129 | 0.767 | 0.103 |
| Raw frequency | 6 |
| Normalized frequency | 0.121 |
| Modifier score | 0.500 |
| Perplexity | 165.377 |